Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GRANULOCYTE COLONY-STIMULATING FACTOR NOS: 2,199 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
2,199
Total FAERS Reports
654 (29.7%)
Deaths Reported
453
Hospitalizations
2,199
As Primary/Secondary Suspect
263
Life-Threatening
6
Disabilities

First Report: 19910930 · Latest Report: 20250712

What Are the Most Common GRANULOCYTE COLONY-STIMULATING FACTOR NOS Side Effects?

#1 Most Reported
Febrile neutropenia
350 reports (15.9%)
#2 Most Reported
Product use in unapproved indication
192 reports (8.7%)
#3 Most Reported
Haematotoxicity
186 reports (8.5%)

All GRANULOCYTE COLONY-STIMULATING FACTOR NOS Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Febrile neutropenia 350 15.9% 65 81
Product use in unapproved indication 192 8.7% 51 32
Haematotoxicity 186 8.5% 20 0
Off label use 169 7.7% 59 50
Death 167 7.6% 167 7
Neutropenia 157 7.1% 27 33
Sepsis 134 6.1% 71 53
Thrombocytopenia 134 6.1% 29 17
Pyrexia 125 5.7% 23 51
Disease progression 119 5.4% 73 9
Mucosal inflammation 100 4.6% 39 28
Diarrhoea 94 4.3% 22 18
Pneumonia 87 4.0% 29 35
Drug ineffective 81 3.7% 30 21
Anaemia 79 3.6% 11 16
Nausea 79 3.6% 16 22
Infection 77 3.5% 35 3
Respiratory failure 72 3.3% 49 26
Acute graft versus host disease 69 3.1% 6 0
Bone marrow failure 65 3.0% 19 9

Who Reports GRANULOCYTE COLONY-STIMULATING FACTOR NOS Side Effects? Age & Gender Data

Gender: 42.2% female, 57.8% male. Average age: 35.6 years. Most reports from: US. View detailed demographics →

Is GRANULOCYTE COLONY-STIMULATING FACTOR NOS Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 1 0 0
2001 1 0 0
2002 3 3 1
2003 1 0 1
2005 1 0 0
2006 1 0 0
2007 2 0 1
2009 1 0 0
2010 1 0 0
2011 6 4 1
2012 12 6 6
2013 18 9 8
2014 33 12 11
2015 66 25 16
2016 62 13 20
2017 36 6 15
2018 30 10 16
2019 55 8 38
2020 39 6 21
2021 19 3 12
2022 21 4 13
2023 40 4 23
2024 27 3 14
2025 10 6 5

View full timeline →

What Is GRANULOCYTE COLONY-STIMULATING FACTOR NOS Used For?

IndicationReports
Acute myeloid leukaemia 344
Product used for unknown indication 249
Prophylaxis 198
Neutropenia 117
Acute lymphocytic leukaemia 102
Peripheral blood stem cell apheresis 66
Stem cell therapy 62
Diffuse large b-cell lymphoma 54
Haematopoietic stem cell mobilisation 51
Bone marrow conditioning regimen 49

GRANULOCYTE COLONY-STIMULATING FACTOR NOS vs Alternatives: Which Is Safer?

GRANULOCYTE COLONY-STIMULATING FACTOR NOS vs GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GRANULOCYTE COLONY-STIMULATING FACTOR NOS vs GRAZOPREVIR GRANULOCYTE COLONY-STIMULATING FACTOR NOS vs GRISEOFULVIN GRANULOCYTE COLONY-STIMULATING FACTOR NOS vs GUAIFENESIN GRANULOCYTE COLONY-STIMULATING FACTOR NOS vs GUAIFENESIN\HYDROCODONE GRANULOCYTE COLONY-STIMULATING FACTOR NOS vs GUAIFENESIN\PSEUDOEPHEDRINE GRANULOCYTE COLONY-STIMULATING FACTOR NOS vs GUANFACINE GRANULOCYTE COLONY-STIMULATING FACTOR NOS vs GUSELKUMAB GRANULOCYTE COLONY-STIMULATING FACTOR NOS vs HAIR KERATIN AMINO ACIDS GOLD COMPLEX GRANULOCYTE COLONY-STIMULATING FACTOR NOS vs HALDOL

Official FDA Label for GRANULOCYTE COLONY-STIMULATING FACTOR NOS

Official prescribing information from the FDA-approved drug label.